Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Umandiagnostics AB
AB
Active
Org 5566982418
Tvistevägen 48, 907 36
Umeå
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2006 · 20 years old
11 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Umandiagnostics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
66M
50M
33M
17M
0M
2020: 19M
19M
2020
2021: 36M (+89% vs 2020)
36M
+89%
2021
2022: 24M (-33% vs 2021)
24M
-33%
2022
2023: 53M (+121% vs 2022)
53M
+121%
2023
2024: 44M (-17% vs 2023)
44M
-17%
2024
EBITDA
SEK millions
46M
35M
23M
12M
0M
2020: 5M
5M
2020
2021: 21M (+320% vs 2020)
21M
+320%
2021
2022: 12M (-43% vs 2021)
12M
-43%
2022
2023: 37M (+208% vs 2022)
37M
+208%
2023
2024: 27M (-27% vs 2023)
27M
-27%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
43 906
53 315
24 185
36 175
18 809
Staff expenses
—
—
—
—
—
EBITDA
27 493
36 703
12 089
21 419
5 487
Depreciation & amort.
−573
−575
−585
−614
−416
EBIT
26 920
36 128
11 504
20 805
5 071
Net financials
2 358
1 375
131
22
−13
Profit before tax
29 279
37 504
11 636
20 826
5 059
Tax
−6 040
−7 733
−2 405
−4 293
−1 090
Net profit
23 239
29 771
9 231
16 533
3 969
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
100 631
76 807
43 385
36 472
18 879
Equity
93 912
70 673
40 903
31 672
15 139
Long-term debt
0
0
0
0
0
Short-term debt
6 719
6 134
2 482
4 801
3 740
Total debt
6 719
6 134
2 482
4 801
3 740
Financial ratios
5-year trend
EBITDA margin
62.6%
This company
15.8%
Market median
This company
Market median
296% above market
2020
2024
Equity ratio
93.3%
This company
38.2%
Market median
This company
Market median
144% above market
2020
2024
Return on equity
24.7%
This company
18.4%
Market median
This company
Market median
34% above market
2020
2024
Net profit margin
52.9%
This company
8.1%
Market median
This company
Market median
553% above market
2020
2024
Asset turnover
0.44×
This company
1.12×
Market median
This company
Market median
61% below market
2020
2024
Debt / equity
0.07×
This company
0.62×
Market median
This company
Market median
89% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Umandiagnostics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
